AstraZeneca

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Request demo

AstraZeneca — overview

About

AstraZeneca is a pharmaceutical company headquartered in Cambridge, UK. It develops and provides medicines designed to fight disease in areas of medical need such as cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory. In November 2023, AstraZeneca launched its subsidiary Evinova, a HealthTech business.

AstraZeneca - known decision makers (10)

Position	Location	Asset Class
Chief Strategy Officer	Cambridge, UK	PE
Executive Director, Chief Executive Officer & Member of the Board	Cambridge, UK	PE
Executive Director, Chief Financial Officer & Member of the Board	Cambridge, UK	PE
Vice President, Corporate Ventures	Cambridge, UK	PE
Executive Vice President, Vaccines & Immune Therapies	Cambridge, UK	PE

Showing 5 of 10 known decision makers AstraZeneca

Preqin screens the most influential contacts in alternatives, so you only reach the key decision makers

Request a demo to see more

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.

Request demo